Impact Factor
3.85
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
4.71
718 total citations
h5-index
37
h5 depth signal
Cited share
82.5%
132 of 160
Total citations
718
Citation footprint
Metric signal
5.53
External metric anchor
Self-citation
5.3%
38 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
Japan
900
United States
63
South Korea
30
China
27
Germany
20
Citing Fields of Research
Allergies
889
Immunology
238
Auto-Inflammatory Disorders
101
Dermatology
62
Hematology
30
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
2,249
Articles tracked across the journal lifetime
Indexed publication set
160
132 cited publications
Last 12 months
96
8.0 publications/month
Open access share
100.0%
96 OA publications in the last year
Leading citing country
Japan
900 citing publications
Leading citing field
Allergies
889 citing publications
Latest tracked publication
14 October 2026
10 recent records available
Coverage & Indexing History
v55n1, Jan. 2006-
v55n1, Jan. 2006-
Research Focus & Classification
Indexed Subjects
Allergies
Issuing & Sponsoring Bodies
Contributor
Nihon Arerugī Gakkai
Broad Categories
Allergy and Immunology
Allergies
MeSH Descriptors
Allergy and Immunology
Hypersensitivity
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1016/j.alit.2026.09.007
Open DOI
Distinct molecular effects of vonoprazan and proton pump inhibitors in eosinophilic esophagitis
02
DOI 10.1016/j.alit.2026.09.002
Open DOI
T cells in chronic spontaneous urticaria show skin-migratory capacity and endotype-specific differences
03
DOI 10.1016/j.alit.2026.09.005
Open DOI
Aberrant distribution of main itch-transducing nerves in a mouse model of atopic dermatitis
04
05
06
07
DOI 10.1016/j.alit.2026.09.004
Open DOI
Adeno-associated virus-mediated epithelial IL-33 silencing attenuates type 2 airway inflammation
08
DOI 10.1016/j.alit.2026.09.001
Open DOI
Childhood asthma as a life-course disease: Recent advances, environmental determinants, and biomarkers
09
DOI 10.1016/j.alit.2026.08.008
Open DOI
Development of a two-step diagnostic algorithm for macadamia nut allergy
10
DOI 10.1016/j.alit.2026.08.007
Open DOI
Serum orexin levels reflect quality of life and symptom burden in patients with allergic rhinitis after nasal surgery
Bibliographical & Catalog Notes
Title from cover.
Adopts its volume and issue numbering from Arerugi.
Also issued online.
Official English language journal of the Society.
v. 1, no. 1 (Mar. 1996)20060921 Notice published Printed on acid-free paper